Phase 4
N=89
Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial
Sinusitis
Bottom Line
View on ClinicalTrials.gov: NCT01919411 ↗Enrolled (actual)
89
Serious AEs
0.0%
Results posted
Feb 2020
Primary outcome: Primary: Sinonasal Outcome Test - 22 — 31.3; 31.0 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Amoxicillin-Potassium Clavulanate (Drug); Placebo (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Massachusetts Eye and Ear Infirmary
- Primary completion
- Sep 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Sinonasal Outcome Test - 22 |
22.3; 17.5 | — |
| PRIMARY Sinonasal Outcome Test - 22 |
22.3; 17.5 | — |
| SECONDARY Lund Kennedy Endoscopic Score |
4.3; 4.5 | — |
| SECONDARY Lund Kennedy Endoscopic Score |
4.3; 4.5 | — |
Summary
Surgeons commonly prescribe post operative prophylactic antibiotics after sinus surgery. There is minimal data to support this. The investigators' study will aim to demonstrate that patients' quality of life and rate of post operative infection is the same whether they receive or do not receive antibiotics post operatively. The investigators hypothesis is that the disease specific quality of life of patients taking post-operative antibiotics is not inferior to the quality of life of patients who do not take post-operative antibiotics, and the rate of post-operative infections are the same. The investigators' specific aim is to compare validated symptom scores between post-operative populations who are given or are not given antibiotics. Rates of infections in the first 10 days after surgery will be recorded. The investigators will also compare endoscopic grades of sinus cavities during the post-operative follow up exams as an additional outcome measure.
Eligibility Criteria
Inclusion Criteria
- Patients eligible for surgery would be patients with chronic rhinosinusitis (defined by the AAOHNS 2007 consensus statement by Rosenfeld et al) and have been determined by their surgeons to have persistent symptoms after maximal medical therapy. Maximal medical therapy is defined as a course of broad spectrum or culture-directed antibiotics used in conjunction with a nasal steroid.
Exclusion Criteria
- Penicillin, cephalosporin, amoxicillin/clavulanate allergy
- Cystic Fibrosis
- Immunodeficiency
- Presence of any foreign body (ie.absorbable and non-absorbable packing) after surgery
- Odontogenic causes of sinusitis
- Fungal ball
- Infected mucocele
- Complication of sinusitis (meningitis, orbital complication, cellulitis, brain abscess)
- Non endoscopic sinus surgery (Caldwell luc, external approaches, etc)
- Age <18
- Pregnant women
Data sourced from ClinicalTrials.gov (NCT01919411). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.